These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2448237)

  • 1. Antigraft responses to the H-28c antigen by B6 and B6D2F1 mice.
    Johnson LL
    Immunogenetics; 1988; 27(3):159-66. PubMed ID: 2448237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the K and I regions of the H-2 complex in resistance to hemopoietic allografts.
    Drizlikh G; Schmidt-Sole J; Yankelevich B
    J Exp Med; 1984 Apr; 159(4):1070-82. PubMed ID: 6142918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cells recognize common antigenic motifs shared by H-2Dd, H-2Ld and possibly H-2Dr molecules expressed on bone marrow cells.
    Yu YY; Forman J; Aldrich C; Blazar B; Flaherty L; Kumar V; Bennett M
    Int Immunol; 1994 Sep; 6(9):1297-306. PubMed ID: 7529556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of leucyl-leucine methyl ester-sensitive cytotoxic cells in skin allograft rejection.
    Thiele DL; Geissler GH; Williams FH; Lipsky PE
    Transplantation; 1992 Jun; 53(6):1334-40. PubMed ID: 1604489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence against suppressor cell involvement in naturally acquired tolerance of a minor histocompatibility antigen.
    Johnson LL
    Transplantation; 1991 Jun; 51(6):1267-71. PubMed ID: 1828638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor MHC class II antigen is essential for induction of transplantation tolerance by bone marrow cells.
    Umemura A; Monaco AP; Maki T
    J Immunol; 2000 May; 164(9):4452-7. PubMed ID: 10779744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of the mutated H-2Kbm1 antigen(s). Test of thyroid graft rejection between B6.C-H-2bm1 and C57BL/6 mice following reciprocal immunization with normal versus malignant cells.
    Isakov N; Segal S
    Immunobiology; 1983 Dec; 165(5):485-99. PubMed ID: 6363278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nature of tolerance in adult recipient mice made tolerant of alloantigens with supralethal irradiation followed by syngeneic bone marrow cell transplantation plus injection of F1 spleen cells.
    Tomita Y; Himeno K; Mayumi H; Tokuda N; Nomoto K
    Transplantation; 1989 Jun; 47(6):1021-9. PubMed ID: 2660340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric donor cells play an active role in both induction and maintenance phases of transplantation tolerance induced by mixed chimerism.
    Kanamoto A; Maki T
    J Immunol; 2004 Feb; 172(3):1444-8. PubMed ID: 14734720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive transfer of skin-selective autoimmunity induced by Skn alloantigenic disparities.
    Jackman SH; Boyse EA; Goldberg EH
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):11041-5. PubMed ID: 1438311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
    Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
    J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provocation of skin graft rejection across murine class II differences by non--bone-marrow-derived cells.
    Stuart PM; Beck-Maier B; Melvold RW
    Transplantation; 1984 Apr; 37(4):393-6. PubMed ID: 6369671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic control of variability in responses to class-I-antigen-disparate thyroid grafts.
    Isakov N; Bach FH
    Transplantation; 1985 Mar; 39(3):303-9. PubMed ID: 3919481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
    Thiele DL; Calomeni JA; Lipsky PE
    J Immunol; 1987 Oct; 139(7):2137-42. PubMed ID: 3309052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressor T cell recognition of major and minor histocompatibility alloantigens: selected suppression of MHC-directed responses by minor alloantigen Ts.
    Perry LL; Williams IR; Dirusso S
    J Immunol; 1984 Jul; 133(1):16-23. PubMed ID: 6202781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell receptor expression in C57BL/6 mice that reject or are rendered tolerant to bm1 cardiac grafts.
    Mohiuddin M; Ruggiero V; Shen Z; DiSesa VJ
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):310-3. PubMed ID: 8751496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H-41, a new minor histocompatibility locus. I. Histogenetic analysis.
    Juretić A; Vucak I; Malenica B; Nagy ZA; Klein J
    J Immunol; 1984 Dec; 133(6):2950-4. PubMed ID: 6386980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin graft rejection in mice repopulated with marrow of the skin donor type: a Skn gene in a congenic line.
    Harrison DE; Mobraaten LE
    Immunogenetics; 1984; 19(6):503-9. PubMed ID: 6376340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and manipulation of T cell immunity to skin grafts expressing a transgenic minor antigen.
    Valujskikh A; Matesic D; Heeger PS
    Transplantation; 1999 Oct; 68(7):1029-36. PubMed ID: 10532546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.